Lebrikizumab vs Other Systemic Monotherapies for Moderate to Severe Atopic Dermatitis: Network Meta-analysis of Short-term Efficacy. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 1, p. s517, 2025. DOI: 10.25251/skin.9.supp.517. Disponível em: https://skin.dermsquared.com/skin/article/view/3159. Acesso em: 24 jun. 2025.